SC to hear pleas over Rs 50 lakh cap on Centre aid for rare diseases
The Supreme Court on Tuesday decided to examine pleas challenging the Rs 50 lakh cap on Centre's assistance for treating ...
Natco Pharma aims to launch generic of Roche’s rare disease drug after favourable ruling in patent infringement case
The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to ...
Natco Pharma shares legal update on Risdiplam product; stock up 3%
The stock rose 2.95 per cent to hit a high of Rs 789. It was last seen trading 1.44 per cent up at Rs 777.45. At this price, ...
Natco Pharma update on launch of Risdiplam in India
The Company has received numerous enquiries from investors and patients about the launch, availability and pricing of generic version of Risdiplam in the Indian market. The Company wishes to clarify ...
Rare diseases policy awaits comprehensive implementation
National Policy for Rare Diseases 2021 addresses diagnosis and treatment, categorizing diseases and advocating for affordable ...
Medical Dialogues2d
Risdiplam Price Disparity in India vs China, Pakistan: SC Issues Notice to Roche
It was submitted that why can't the Indian government negotiate with Roche to make the medicine for the rare disorder ...
Can cheaper SMA medicine be made available in India, asks SC
Can the medicine for treatment of rare disorder spinal muscular atrophy (SMA) be made available at lower price in India, if ...
Supreme Court seeks Centre’s reply on cheaper medicines for rare spinal disorder
The Supreme Court on Friday asked the Centre and the manufacturer of the drug Risdiplam, which is used for the treatment of ...
Can med for rare disorder SMA be made available at lower price in India: SC to drug manufacturer
New Delhi, Can the medicine for treatment of rare disorder spinal muscular atrophy be made available at lower price in India if it is supplied to the neighbouring countries Pakistan and China at a ...